825,000 Shares in Seer, Inc. $SEER Purchased by Nano Cap New Millennium Growth Fund L P

Nano Cap New Millennium Growth Fund L P bought a new position in shares of Seer, Inc. (NASDAQ:SEER) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 825,000 shares of the company’s stock, valued at approximately $1,510,000. Seer accounts for approximately 1.3% of Nano Cap New Millennium Growth Fund L P’s portfolio, making the stock its 20th largest holding. Nano Cap New Millennium Growth Fund L P owned about 1.48% of Seer as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in SEER. Occudo Quantitative Strategies LP purchased a new position in Seer in the second quarter valued at $25,000. Corient Private Wealth LLC increased its holdings in Seer by 46.3% in the second quarter. Corient Private Wealth LLC now owns 63,200 shares of the company’s stock valued at $135,000 after buying an additional 20,000 shares in the last quarter. Shay Capital LLC increased its holdings in Seer by 17.7% in the third quarter. Shay Capital LLC now owns 73,571 shares of the company’s stock valued at $160,000 after buying an additional 11,073 shares in the last quarter. XTX Topco Ltd purchased a new position in Seer in the second quarter valued at $172,000. Finally, Squarepoint Ops LLC increased its holdings in Seer by 57.0% in the third quarter. Squarepoint Ops LLC now owns 91,906 shares of the company’s stock valued at $199,000 after buying an additional 33,349 shares in the last quarter. Hedge funds and other institutional investors own 75.20% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on SEER shares. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Seer in a research note on Tuesday, April 21st. TD Cowen raised Seer to a “strong-buy” rating in a research note on Monday, April 13th. Finally, Canaccord Genuity Group initiated coverage on shares of Seer in a research note on Monday, May 4th. They issued a “buy” rating and a $4.00 price target on the stock. Two equities research analysts have rated the stock with a Strong Buy rating and one has given a Sell rating to the stock. According to data from MarketBeat, Seer currently has an average rating of “Buy” and a consensus price target of $4.00.

Seer Trading Up 5.4%

Seer stock opened at $1.77 on Friday. Seer, Inc. has a 12-month low of $1.65 and a 12-month high of $2.41. The stock has a market cap of $99.86 million, a P/E ratio of -1.43 and a beta of 1.63. The company has a 50-day moving average price of $1.80 and a 200 day moving average price of $1.87.

Seer (NASDAQ:SEER) last released its quarterly earnings data on Wednesday, May 13th. The company reported ($0.30) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.30). Seer had a negative net margin of 464.78% and a negative return on equity of 26.58%. The firm had revenue of $2.79 million during the quarter, compared to analysts’ expectations of $3.60 million.

Seer Company Profile

Seer, Inc is a life sciences company focused on pioneering next-generation proteomics, the large-scale study of proteins and their functions in complex biological systems. By leveraging proprietary nanoparticle-based technology, Seer’s platform enables high-throughput, unbiased protein analysis from biological samples, addressing a critical bottleneck in drug discovery, biomarker research and precision medicine.

The company’s flagship Proteograph Product Suite combines engineered nanoparticle assays with advanced mass spectrometry and bioinformatics pipelines to deliver deep proteomic coverage in a scalable workflow.